Loading clinical trials...
Loading clinical trials...
Clinical Characteristics, Risk Factors and Resistance Mechanisms for Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis
Conditions
Interventions
Non-Interventional Research
Locations
1
Turkey (Türkiye)
Dokuz Eylül University
Izmir, Turkey (Türkiye)
Start Date
January 1, 2018
Primary Completion Date
December 31, 2021
Completion Date
January 1, 2023
Last Updated
August 7, 2024
NCT06650501
NCT07299539
NCT06135350
NCT07004049
NCT06336824
NCT06874920
Lead Sponsor
Dokuz Eylul University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions